

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.86918279 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.47749980 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.68878400 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.68878400 |
| 5 | oxygen transport (GO:0015671) | 5.60069662 |
| 6 | heme biosynthetic process (GO:0006783) | 5.41904737 |
| 7 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.04854556 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.98408937 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.98408937 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.98408937 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.98408937 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.98408937 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.98408937 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 4.90118844 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.73271234 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69835586 |
| 17 | gas transport (GO:0015669) | 4.67704115 |
| 18 | tetrapyrrole biosynthetic process (GO:0033014) | 4.56626560 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.53938981 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.53938981 |
| 21 | erythrocyte maturation (GO:0043249) | 4.52339001 |
| 22 | detection of other organism (GO:0098543) | 4.49562254 |
| 23 | detection of bacterium (GO:0016045) | 4.45902791 |
| 24 | heme metabolic process (GO:0042168) | 4.40345209 |
| 25 | leukocyte aggregation (GO:0070486) | 4.16263479 |
| 26 | porphyrin-containing compound metabolic process (GO:0006778) | 4.09083933 |
| 27 | definitive hemopoiesis (GO:0060216) | 3.99754090 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95828212 |
| 29 | response to peptidoglycan (GO:0032494) | 3.88684982 |
| 30 | positive regulation of granulocyte differentiation (GO:0030854) | 3.86340473 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85761404 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.80761598 |
| 33 | cellular extravasation (GO:0045123) | 3.79708304 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.79204128 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.74903265 |
| 36 | respiratory burst (GO:0045730) | 3.72369915 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.72320515 |
| 38 | viral transcription (GO:0019083) | 3.72023940 |
| 39 | response to interleukin-15 (GO:0070672) | 3.71129730 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65674988 |
| 41 | translational termination (GO:0006415) | 3.59139114 |
| 42 | microglial cell activation (GO:0001774) | 3.55006935 |
| 43 | negative T cell selection (GO:0043383) | 3.52433668 |
| 44 | DNA deamination (GO:0045006) | 3.51992140 |
| 45 | negative thymic T cell selection (GO:0045060) | 3.50317082 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 3.46165046 |
| 47 | erythrocyte development (GO:0048821) | 3.45223665 |
| 48 | response to host immune response (GO:0052572) | 3.42225452 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42225452 |
| 50 | neutrophil activation (GO:0042119) | 3.40703970 |
| 51 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.40693952 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40487757 |
| 53 | positive T cell selection (GO:0043368) | 3.38207871 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.36275904 |
| 55 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.35411632 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.35287483 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.34241176 |
| 58 | neutrophil mediated immunity (GO:0002446) | 3.33990472 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 3.33404243 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31058621 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.30133862 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30021875 |
| 63 | translational elongation (GO:0006414) | 3.25486028 |
| 64 | megakaryocyte development (GO:0035855) | 3.25251585 |
| 65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25043007 |
| 66 | purine-containing compound salvage (GO:0043101) | 3.24200189 |
| 67 | DNA strand elongation (GO:0022616) | 3.24143276 |
| 68 | embryonic hemopoiesis (GO:0035162) | 3.21344109 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.20562048 |
| 70 | T cell migration (GO:0072678) | 3.19358656 |
| 71 | detection of molecule of bacterial origin (GO:0032490) | 3.17817343 |
| 72 | leukocyte degranulation (GO:0043299) | 3.17515390 |
| 73 | granulocyte activation (GO:0036230) | 3.17346598 |
| 74 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16404566 |
| 75 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.15304757 |
| 76 | regulation of granulocyte differentiation (GO:0030852) | 3.14224051 |
| 77 | DNA unwinding involved in DNA replication (GO:0006268) | 3.13227912 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12416296 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.11748249 |
| 80 | DNA replication initiation (GO:0006270) | 3.11280725 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11014567 |
| 82 | response to host (GO:0075136) | 3.11014567 |
| 83 | response to host defenses (GO:0052200) | 3.11014567 |
| 84 | T cell selection (GO:0045058) | 3.10715133 |
| 85 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.09734364 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.06948115 |
| 87 | thymic T cell selection (GO:0045061) | 3.06231052 |
| 88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.04959623 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.03269216 |
| 90 | macrophage activation (GO:0042116) | 3.03040156 |
| 91 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01988801 |
| 92 | response to interferon-beta (GO:0035456) | 3.01625223 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 3.01033783 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 2.99038906 |
| 95 | protein targeting to ER (GO:0045047) | 2.98773003 |
| 96 | cotranslational protein targeting to membrane (GO:0006613) | 2.98662559 |
| 97 | regulation of erythrocyte differentiation (GO:0045646) | 2.98597566 |
| 98 | regulation of platelet aggregation (GO:0090330) | 2.96463751 |
| 99 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.96085462 |
| 100 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.95492323 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95268537 |
| 102 | modulation by virus of host process (GO:0019054) | 2.95173833 |
| 103 | telomere maintenance via recombination (GO:0000722) | 2.94278255 |
| 104 | erythrocyte differentiation (GO:0030218) | 2.93458638 |
| 105 | necroptotic process (GO:0070266) | 2.88894872 |
| 106 | tolerance induction (GO:0002507) | 2.88569135 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 2.88493967 |
| 108 | myeloid cell development (GO:0061515) | 2.86168201 |
| 109 | myeloid leukocyte mediated immunity (GO:0002444) | 2.86101916 |
| 110 | response to muramyl dipeptide (GO:0032495) | 2.86015762 |
| 111 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.84912020 |
| 112 | regulation of tolerance induction (GO:0002643) | 2.83433334 |
| 113 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83072294 |
| 114 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83072294 |
| 115 | protein localization to endoplasmic reticulum (GO:0070972) | 2.82095995 |
| 116 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81968949 |
| 117 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.78552997 |
| 118 | negative regulation of innate immune response (GO:0045824) | 2.76718472 |
| 119 | hemoglobin metabolic process (GO:0020027) | 2.76628100 |
| 120 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.75967400 |
| 121 | viral life cycle (GO:0019058) | 2.73670364 |
| 122 | response to interferon-alpha (GO:0035455) | 2.73411146 |
| 123 | translational initiation (GO:0006413) | 2.73302129 |
| 124 | ribosomal small subunit biogenesis (GO:0042274) | 2.72313293 |
| 125 | response to type I interferon (GO:0034340) | 2.70622030 |
| 126 | tetrapyrrole metabolic process (GO:0033013) | 2.70247710 |
| 127 | IMP biosynthetic process (GO:0006188) | 2.67759549 |
| 128 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66793991 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.66439199 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.66439199 |
| 131 | IMP metabolic process (GO:0046040) | 2.63596032 |
| 132 | mitotic recombination (GO:0006312) | 2.63584790 |
| 133 | regulation of necroptotic process (GO:0060544) | 2.63578309 |
| 134 | cellular protein complex disassembly (GO:0043624) | 2.62377364 |
| 135 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60634376 |
| 136 | NIK/NF-kappaB signaling (GO:0038061) | 2.57928857 |
| 137 | maturation of SSU-rRNA (GO:0030490) | 2.57401107 |
| 138 | granulocyte differentiation (GO:0030851) | 2.57214923 |
| 139 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.55497133 |
| 140 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.55388160 |
| 141 | cellular response to zinc ion (GO:0071294) | 2.53076410 |
| 142 | formation of translation preinitiation complex (GO:0001731) | 2.52807046 |
| 143 | angiogenesis involved in wound healing (GO:0060055) | 2.50180069 |
| 144 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.49731112 |
| 145 | telomere maintenance via telomere lengthening (GO:0010833) | 2.49279718 |
| 146 | defense response to protozoan (GO:0042832) | 2.49142962 |
| 147 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.47858560 |
| 148 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.47493503 |
| 149 | cellular response to interferon-beta (GO:0035458) | 2.47458215 |
| 150 | myeloid dendritic cell activation (GO:0001773) | 2.47102706 |
| 151 | negative regulation of viral entry into host cell (GO:0046597) | 2.46499267 |
| 152 | regulation of RIG-I signaling pathway (GO:0039535) | 2.46029512 |
| 153 | immunoglobulin mediated immune response (GO:0016064) | 2.45386191 |
| 154 | valine metabolic process (GO:0006573) | 2.45272842 |
| 155 | T cell homeostasis (GO:0043029) | 2.44300444 |
| 156 | platelet dense granule organization (GO:0060155) | 2.43384697 |
| 157 | regulation of B cell differentiation (GO:0045577) | 2.42809185 |
| 158 | regulation of natural killer cell differentiation (GO:0032823) | 2.42708902 |
| 159 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39219191 |
| 160 | pigment biosynthetic process (GO:0046148) | 2.37955229 |
| 161 | protein complex disassembly (GO:0043241) | 2.34697626 |
| 162 | regulation of necrotic cell death (GO:0010939) | 2.34673942 |
| 163 | response to protozoan (GO:0001562) | 2.34366238 |
| 164 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.32810152 |
| 165 | negative regulation of viral genome replication (GO:0045071) | 2.31887837 |
| 166 | negative regulation of bone mineralization (GO:0030502) | 2.29961336 |
| 167 | natural killer cell differentiation (GO:0001779) | 2.28037109 |
| 168 | B cell mediated immunity (GO:0019724) | 2.27269377 |
| 169 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.26425310 |
| 170 | lymph node development (GO:0048535) | 2.26409931 |
| 171 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.23517868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.33027529 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.25115048 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.16438252 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.05033057 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03758158 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.51197292 |
| 7 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.50230369 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.49854555 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49150579 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.48311464 |
| 11 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.41259297 |
| 12 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31519290 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.30478619 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26672889 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.20318314 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.18060731 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.17782137 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15564463 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.07151046 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05800382 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.04866589 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02850283 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.01603612 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99034064 |
| 25 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.96720217 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95522555 |
| 27 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.93695981 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93082887 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91944955 |
| 30 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.91262604 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87810790 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.87464708 |
| 33 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.87245437 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83325299 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82524629 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81451533 |
| 37 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80392752 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.79716055 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.78298573 |
| 40 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.78074706 |
| 41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76213843 |
| 42 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.73130147 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69414133 |
| 44 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67554402 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.65015207 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64761195 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62762838 |
| 48 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.61988849 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61027776 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58722879 |
| 51 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.58718357 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.58288018 |
| 53 | * MAF_26560356_Chip-Seq_TH1_Human | 1.58015915 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55914680 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55617561 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.55512658 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53559294 |
| 58 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52931326 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51877229 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50832170 |
| 61 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.50470182 |
| 62 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.49785928 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48035206 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47049703 |
| 65 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.46039307 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45696958 |
| 67 | * MYB_26560356_Chip-Seq_TH2_Human | 1.45615039 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45314472 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.45226634 |
| 70 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44166238 |
| 71 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.44033163 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43958029 |
| 73 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.42453945 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42340576 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40254467 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39759698 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39486428 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38151011 |
| 79 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.37970604 |
| 80 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.36855936 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36785970 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.35531856 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35233355 |
| 84 | * MYB_26560356_Chip-Seq_TH1_Human | 1.33439980 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32783947 |
| 86 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.30845740 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30157859 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29684323 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28976380 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28083959 |
| 91 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.28058757 |
| 92 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27803379 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26998730 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26763704 |
| 95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26588847 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26456596 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26024384 |
| 98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25788982 |
| 99 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25770029 |
| 100 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25713930 |
| 101 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25394236 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25096818 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24018745 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22419238 |
| 105 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21152185 |
| 106 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20608189 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20104291 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18852345 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18157090 |
| 110 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18113418 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18079458 |
| 112 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.17543101 |
| 113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16467408 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15336814 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14731879 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14392280 |
| 117 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.14089107 |
| 118 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13686006 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13432075 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12975051 |
| 121 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11780865 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11440076 |
| 123 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10945551 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09568699 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08632194 |
| 126 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07547185 |
| 127 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05769678 |
| 128 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05675651 |
| 129 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04543272 |
| 130 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03824091 |
| 131 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03637703 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02645436 |
| 133 | * MAF_26560356_Chip-Seq_TH2_Human | 1.02237769 |
| 134 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.00827435 |
| 135 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99451848 |
| 136 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99157601 |
| 137 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98994253 |
| 138 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98583303 |
| 139 | P68_20966046_ChIP-Seq_HELA_Human | 0.98214628 |
| 140 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98105128 |
| 141 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97654459 |
| 142 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.96896423 |
| 143 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95264057 |
| 144 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92045579 |
| 145 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86068220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 4.82977792 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 4.43258333 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.32474876 |
| 4 | MP0001545_abnormal_hematopoietic_system | 2.81806309 |
| 5 | MP0005397_hematopoietic_system_phenotyp | 2.81806309 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.75161683 |
| 7 | MP0000685_abnormal_immune_system | 2.67865214 |
| 8 | MP0006054_spinal_hemorrhage | 2.37885963 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.32688538 |
| 10 | MP0009785_altered_susceptibility_to | 2.17901321 |
| 11 | MP0005671_abnormal_response_to | 2.11398768 |
| 12 | MP0002398_abnormal_bone_marrow | 2.05894369 |
| 13 | MP0008260_abnormal_autophagy | 2.05139342 |
| 14 | MP0003172_abnormal_lysosome_physiology | 1.93009719 |
| 15 | MP0005464_abnormal_platelet_physiology | 1.91523531 |
| 16 | MP0003724_increased_susceptibility_to | 1.85642995 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.84017505 |
| 18 | MP0005025_abnormal_response_to | 1.83604001 |
| 19 | MP0001853_heart_inflammation | 1.81991986 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.79486610 |
| 21 | MP0010094_abnormal_chromosome_stability | 1.78724807 |
| 22 | MP0001800_abnormal_humoral_immune | 1.78699948 |
| 23 | MP0003436_decreased_susceptibility_to | 1.76063873 |
| 24 | MP0000490_abnormal_crypts_of | 1.73832488 |
| 25 | MP0000689_abnormal_spleen_morphology | 1.73650784 |
| 26 | MP0005451_abnormal_body_composition | 1.71461172 |
| 27 | MP0002722_abnormal_immune_system | 1.69681975 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.68723592 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.67535584 |
| 30 | MP0003077_abnormal_cell_cycle | 1.67329345 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.65949877 |
| 32 | MP0010368_abnormal_lymphatic_system | 1.63832791 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.63527128 |
| 34 | MP0002429_abnormal_blood_cell | 1.62012930 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.61677856 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.61448410 |
| 37 | MP0001819_abnormal_immune_cell | 1.60210219 |
| 38 | MP0008057_abnormal_DNA_replication | 1.58918663 |
| 39 | MP0002723_abnormal_immune_serum | 1.57837466 |
| 40 | MP0001790_abnormal_immune_system | 1.56973010 |
| 41 | MP0005387_immune_system_phenotype | 1.56973010 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.56059822 |
| 43 | MP0000716_abnormal_immune_system | 1.54646836 |
| 44 | MP0004381_abnormal_hair_follicle | 1.51775622 |
| 45 | MP0008007_abnormal_cellular_replicative | 1.49489214 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.46814447 |
| 47 | MP0002419_abnormal_innate_immunity | 1.46806369 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.36416841 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.34697388 |
| 50 | MP0002405_respiratory_system_inflammati | 1.34529075 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.34393749 |
| 52 | MP0003186_abnormal_redox_activity | 1.31543803 |
| 53 | MP0000343_altered_response_to | 1.31526902 |
| 54 | MP0002006_tumorigenesis | 1.29933184 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.28703293 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.26306125 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.24356736 |
| 58 | MP0003279_aneurysm | 1.20900256 |
| 59 | MP0002132_abnormal_respiratory_system | 1.18548428 |
| 60 | MP0001879_abnormal_lymphatic_vessel | 1.18498524 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.17352946 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.16971495 |
| 63 | MP0009278_abnormal_bone_marrow | 1.16795419 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 1.16567797 |
| 65 | MP0001851_eye_inflammation | 1.14885516 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.13213859 |
| 67 | MP0008058_abnormal_DNA_repair | 1.12713132 |
| 68 | MP0008469_abnormal_protein_level | 1.11750217 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.11619064 |
| 70 | MP0010307_abnormal_tumor_latency | 1.08668324 |
| 71 | MP0009764_decreased_sensitivity_to | 1.06256349 |
| 72 | MP0005310_abnormal_salivary_gland | 1.06142903 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.03886383 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 1.03219193 |
| 75 | MP0004883_abnormal_blood_vessel | 1.02108967 |
| 76 | MP0001873_stomach_inflammation | 0.99686828 |
| 77 | MP0000858_altered_metastatic_potential | 0.99018357 |
| 78 | MP0008775_abnormal_heart_ventricle | 0.98209169 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.96513046 |
| 80 | MP0003183_abnormal_peptide_metabolism | 0.96373865 |
| 81 | MP0000313_abnormal_cell_death | 0.94565219 |
| 82 | MP0009763_increased_sensitivity_to | 0.93499012 |
| 83 | MP0001663_abnormal_digestive_system | 0.93325569 |
| 84 | MP0004130_abnormal_muscle_cell | 0.92666855 |
| 85 | MP0001533_abnormal_skeleton_physiology | 0.92486073 |
| 86 | MP0005083_abnormal_biliary_tract | 0.92264197 |
| 87 | MP0002933_joint_inflammation | 0.90303786 |
| 88 | MP0005023_abnormal_wound_healing | 0.89045863 |
| 89 | MP0004947_skin_inflammation | 0.89034034 |
| 90 | MP0003300_gastrointestinal_ulcer | 0.88889877 |
| 91 | MP0003075_altered_response_to | 0.88758169 |
| 92 | MP0005503_abnormal_tendon_morphology | 0.88200869 |
| 93 | MP0003828_pulmonary_edema | 0.87842303 |
| 94 | MP0000749_muscle_degeneration | 0.87820089 |
| 95 | MP0003878_abnormal_ear_physiology | 0.87740259 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.87740259 |
| 97 | MP0003705_abnormal_hypodermis_morpholog | 0.86893301 |
| 98 | MP0004510_myositis | 0.86282140 |
| 99 | MP0000598_abnormal_liver_morphology | 0.84493842 |
| 100 | MP0005164_abnormal_response_to | 0.84001815 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.83690531 |
| 102 | MP0009840_abnormal_foam_cell | 0.83164554 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82835216 |
| 104 | MP0006082_CNS_inflammation | 0.81970279 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81611771 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.80838771 |
| 107 | MP0003866_abnormal_defecation | 0.80243510 |
| 108 | MP0003943_abnormal_hepatobiliary_system | 0.79846504 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.79367429 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.78443007 |
| 111 | MP0003303_peritoneal_inflammation | 0.77097628 |
| 112 | MP0000350_abnormal_cell_proliferation | 0.76290636 |
| 113 | MP0001243_abnormal_dermal_layer | 0.76022231 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.74815345 |
| 115 | MP0001915_intracranial_hemorrhage | 0.74537937 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.73524412 |
| 117 | MP0005275_abnormal_skin_tensile | 0.72239910 |
| 118 | MP0005390_skeleton_phenotype | 0.71661991 |
| 119 | MP0009931_abnormal_skin_appearance | 0.71231577 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.71152654 |
| 121 | MP0000609_abnormal_liver_physiology | 0.70237945 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.69397016 |
| 123 | MP0005166_decreased_susceptibility_to | 0.69340297 |
| 124 | MP0003795_abnormal_bone_structure | 0.66605937 |
| 125 | MP0003448_altered_tumor_morphology | 0.65502087 |
| 126 | MP0000604_amyloidosis | 0.64214468 |
| 127 | MP0003045_fibrosis | 0.63840775 |
| 128 | MP0003690_abnormal_glial_cell | 0.63589749 |
| 129 | MP0008874_decreased_physiological_sensi | 0.62597103 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.59940785 |
| 131 | MP0000249_abnormal_blood_vessel | 0.57672250 |
| 132 | MP0008004_abnormal_stomach_pH | 0.54091646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.20669982 |
| 2 | Poikilocytosis (HP:0004447) | 5.49743868 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.80221175 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.59350960 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.46034645 |
| 6 | Stomatitis (HP:0010280) | 4.36297424 |
| 7 | Thrombocytosis (HP:0001894) | 4.12343420 |
| 8 | Orchitis (HP:0100796) | 4.08553443 |
| 9 | Obstructive lung disease (HP:0006536) | 4.07963562 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07963562 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.06460566 |
| 12 | Petechiae (HP:0000967) | 3.95273299 |
| 13 | Acanthocytosis (HP:0001927) | 3.94736999 |
| 14 | Abnormal hemoglobin (HP:0011902) | 3.80436970 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.69315398 |
| 16 | Optic neuritis (HP:0100653) | 3.69315398 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.61737164 |
| 18 | Meningitis (HP:0001287) | 3.61618064 |
| 19 | Reticulocytosis (HP:0001923) | 3.61606921 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.49864624 |
| 21 | Prolonged bleeding time (HP:0003010) | 3.49026223 |
| 22 | Increased IgE level (HP:0003212) | 3.39172081 |
| 23 | Microcytic anemia (HP:0001935) | 3.34452211 |
| 24 | Aplastic anemia (HP:0001915) | 3.31198196 |
| 25 | Encephalitis (HP:0002383) | 3.23587483 |
| 26 | Abnormality of reticulocytes (HP:0004312) | 3.23348462 |
| 27 | Chronic otitis media (HP:0000389) | 3.23239132 |
| 28 | Polycythemia (HP:0001901) | 3.16230588 |
| 29 | IgM deficiency (HP:0002850) | 3.13759056 |
| 30 | Gingivitis (HP:0000230) | 3.02562673 |
| 31 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.00687816 |
| 32 | Epistaxis (HP:0000421) | 2.99275273 |
| 33 | Hyperbilirubinemia (HP:0002904) | 2.96790201 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94896260 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94896260 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 2.92870805 |
| 37 | T lymphocytopenia (HP:0005403) | 2.91948345 |
| 38 | Increased serum ferritin (HP:0003281) | 2.90554996 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 2.87346642 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.85796708 |
| 41 | Chest pain (HP:0100749) | 2.84939792 |
| 42 | Hypochromic anemia (HP:0001931) | 2.84786327 |
| 43 | Granulocytopenia (HP:0001913) | 2.82461115 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.78457983 |
| 45 | Leukocytosis (HP:0001974) | 2.75511934 |
| 46 | Keratoconjunctivitis (HP:0001096) | 2.70503185 |
| 47 | Nausea (HP:0002018) | 2.70499819 |
| 48 | Cholelithiasis (HP:0001081) | 2.70016514 |
| 49 | Increased IgM level (HP:0003496) | 2.66651295 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.63236691 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.61382557 |
| 52 | Impaired platelet aggregation (HP:0003540) | 2.59573862 |
| 53 | Abnormal platelet function (HP:0011869) | 2.59573862 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.59099546 |
| 55 | Osteomyelitis (HP:0002754) | 2.56490984 |
| 56 | Pallor (HP:0000980) | 2.56204583 |
| 57 | Reticulocytopenia (HP:0001896) | 2.55333424 |
| 58 | Myositis (HP:0100614) | 2.54908185 |
| 59 | Toxemia of pregnancy (HP:0100603) | 2.53347018 |
| 60 | Recurrent viral infections (HP:0004429) | 2.52824767 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.51802282 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.49796350 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.49196683 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.48877487 |
| 65 | Nonimmune hydrops fetalis (HP:0001790) | 2.48561153 |
| 66 | Episodic fever (HP:0001954) | 2.46181231 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.42128547 |
| 68 | Slow saccadic eye movements (HP:0000514) | 2.41915578 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.40763356 |
| 70 | Diaphragmatic weakness (HP:0009113) | 2.37618395 |
| 71 | Purpura (HP:0000979) | 2.36819704 |
| 72 | Autoimmune hemolytic anemia (HP:0001890) | 2.34175266 |
| 73 | Anorexia (HP:0002039) | 2.34033136 |
| 74 | Amaurosis fugax (HP:0100576) | 2.33739447 |
| 75 | Paralysis (HP:0003470) | 2.33092185 |
| 76 | Hemoptysis (HP:0002105) | 2.32191878 |
| 77 | Colitis (HP:0002583) | 2.32026544 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.31080826 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.30893437 |
| 80 | Nasal polyposis (HP:0100582) | 2.29237306 |
| 81 | Eosinophilia (HP:0001880) | 2.26866436 |
| 82 | Birth length less than 3rd percentile (HP:0003561) | 2.26013512 |
| 83 | Hypertensive crisis (HP:0100735) | 2.25504156 |
| 84 | Arterial thrombosis (HP:0004420) | 2.23452825 |
| 85 | Vertebral compression fractures (HP:0002953) | 2.22098251 |
| 86 | Cellulitis (HP:0100658) | 2.21418046 |
| 87 | Sepsis (HP:0100806) | 2.20005444 |
| 88 | Abnormality of T cells (HP:0002843) | 2.19970606 |
| 89 | Cutaneous photosensitivity (HP:0000992) | 2.18499128 |
| 90 | Recurrent bacterial skin infections (HP:0005406) | 2.17248997 |
| 91 | Pulmonary embolism (HP:0002204) | 2.15713735 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.12555502 |
| 93 | Abnormal platelet volume (HP:0011876) | 2.09954183 |
| 94 | Urticaria (HP:0001025) | 2.06660689 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 2.06306605 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 2.05052161 |
| 97 | Gingival bleeding (HP:0000225) | 2.04712438 |
| 98 | Macrocytic anemia (HP:0001972) | 2.04051479 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.03909418 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03455419 |
| 101 | Acute myeloid leukemia (HP:0004808) | 2.02210797 |
| 102 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.99581269 |
| 103 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.99581269 |
| 104 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99038736 |
| 105 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98562490 |
| 106 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98562490 |
| 107 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98562490 |
| 108 | Short middle phalanx of the 5th finger (HP:0004220) | 1.98436614 |
| 109 | Neoplasm of head and neck (HP:0012288) | 1.98034769 |
| 110 | Esophageal neoplasm (HP:0100751) | 1.98034769 |
| 111 | Pustule (HP:0200039) | 1.94257709 |
| 112 | Abnormality of eosinophils (HP:0001879) | 1.91640309 |
| 113 | Skin rash (HP:0000988) | 1.91563758 |
| 114 | Abnormal gallbladder physiology (HP:0012438) | 1.89871314 |
| 115 | Cholecystitis (HP:0001082) | 1.89871314 |
| 116 | Abnormality of the pleura (HP:0002103) | 1.89519023 |
| 117 | Exertional dyspnea (HP:0002875) | 1.89080382 |
| 118 | Lymphoma (HP:0002665) | 1.88382123 |
| 119 | Skin ulcer (HP:0200042) | 1.88054376 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.87982072 |
| 121 | Hematochezia (HP:0002573) | 1.87240935 |
| 122 | Peritonitis (HP:0002586) | 1.87075551 |
| 123 | Splenomegaly (HP:0001744) | 1.86577252 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.85859605 |
| 125 | Severe combined immunodeficiency (HP:0004430) | 1.85287414 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.84096811 |
| 127 | Verrucae (HP:0200043) | 1.83781509 |
| 128 | Papilloma (HP:0012740) | 1.83781509 |
| 129 | Fatigue (HP:0012378) | 1.83376485 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.81901055 |
| 131 | Increased muscle lipid content (HP:0009058) | 1.80920841 |
| 132 | Eczematoid dermatitis (HP:0000976) | 1.78532744 |
| 133 | IgG deficiency (HP:0004315) | 1.78033395 |
| 134 | Hepatic necrosis (HP:0002605) | 1.77745969 |
| 135 | Vasculitis (HP:0002633) | 1.77464642 |
| 136 | Hypertriglyceridemia (HP:0002155) | 1.77125039 |
| 137 | Beaking of vertebral bodies (HP:0004568) | 1.76953120 |
| 138 | Thrombophlebitis (HP:0004418) | 1.75684368 |
| 139 | Myelodysplasia (HP:0002863) | 1.74054876 |
| 140 | Pancytopenia (HP:0001876) | 1.73510800 |
| 141 | Abnormality of B cell number (HP:0010975) | 1.72360126 |
| 142 | B lymphocytopenia (HP:0010976) | 1.72360126 |
| 143 | Broad palm (HP:0001169) | 1.70477552 |
| 144 | Gastrointestinal stroma tumor (HP:0100723) | 1.69889032 |
| 145 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68163833 |
| 146 | Abnormality of the prostate (HP:0008775) | 1.68035721 |
| 147 | Rhabdomyolysis (HP:0003201) | 1.67558936 |
| 148 | Abnormality of the fingertips (HP:0001211) | 1.67037887 |
| 149 | Recurrent skin infections (HP:0001581) | 1.66869588 |
| 150 | Multiple enchondromatosis (HP:0005701) | 1.66580739 |
| 151 | Ankle contracture (HP:0006466) | 1.65814653 |
| 152 | Hepatocellular carcinoma (HP:0001402) | 1.65628084 |
| 153 | Gastrointestinal inflammation (HP:0004386) | 1.63188062 |
| 154 | Generalized aminoaciduria (HP:0002909) | 1.61476516 |
| 155 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.61319848 |
| 156 | Neutropenia (HP:0001875) | 1.60701308 |
| 157 | Increased intramyocellular lipid droplets (HP:0012240) | 1.60411261 |
| 158 | Lymphopenia (HP:0001888) | 1.60384706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.13831599 |
| 2 | EIF2AK1 | 2.97755592 |
| 3 | MAP4K1 | 2.92328341 |
| 4 | NME2 | 2.85470268 |
| 5 | PRPF4B | 2.69309891 |
| 6 | KIT | 2.58273731 |
| 7 | FES | 2.51672862 |
| 8 | JAK3 | 2.32115190 |
| 9 | FLT3 | 2.28734096 |
| 10 | TNK2 | 2.27042240 |
| 11 | EEF2K | 2.19026853 |
| 12 | MAP2K3 | 2.17749321 |
| 13 | KDR | 2.12823335 |
| 14 | TAOK1 | 2.09810042 |
| 15 | CSK | 2.09071102 |
| 16 | CDC7 | 2.08554803 |
| 17 | MAP3K3 | 2.06995006 |
| 18 | TYK2 | 2.02386532 |
| 19 | TIE1 | 1.99945084 |
| 20 | ACVR1B | 1.99751925 |
| 21 | TGFBR1 | 1.91804369 |
| 22 | TBK1 | 1.90696344 |
| 23 | PIM2 | 1.82349147 |
| 24 | TGFBR2 | 1.77339333 |
| 25 | ZAP70 | 1.72271614 |
| 26 | PKN2 | 1.71386356 |
| 27 | TRIB3 | 1.65934620 |
| 28 | BTK | 1.61774919 |
| 29 | TEC | 1.61019501 |
| 30 | STK4 | 1.58741006 |
| 31 | ERN1 | 1.57814044 |
| 32 | FGR | 1.57542512 |
| 33 | WEE1 | 1.51668601 |
| 34 | IKBKE | 1.45615484 |
| 35 | MAP3K1 | 1.44914362 |
| 36 | RPS6KA4 | 1.43894654 |
| 37 | VRK1 | 1.40142822 |
| 38 | EPHB1 | 1.39500985 |
| 39 | PIM1 | 1.38627557 |
| 40 | TESK2 | 1.38284870 |
| 41 | STK10 | 1.37851209 |
| 42 | IKBKB | 1.33990692 |
| 43 | BUB1 | 1.33210751 |
| 44 | MARK3 | 1.32888338 |
| 45 | TLK1 | 1.32054730 |
| 46 | SCYL2 | 1.30935693 |
| 47 | IRAK4 | 1.27928627 |
| 48 | NEK2 | 1.27482046 |
| 49 | SYK | 1.21538431 |
| 50 | BCKDK | 1.20444764 |
| 51 | MAP3K10 | 1.20120700 |
| 52 | LRRK2 | 1.18601344 |
| 53 | NEK9 | 1.13426665 |
| 54 | MAP3K14 | 1.11529730 |
| 55 | MAP3K11 | 1.10776534 |
| 56 | TXK | 1.10036247 |
| 57 | MAPKAPK3 | 1.07941666 |
| 58 | CSF1R | 1.05685602 |
| 59 | KSR2 | 1.05404086 |
| 60 | BLK | 1.05284023 |
| 61 | DYRK3 | 1.05061368 |
| 62 | STK16 | 1.02792919 |
| 63 | RPS6KB2 | 1.00064642 |
| 64 | BRSK2 | 0.99826958 |
| 65 | MAP3K13 | 0.98083029 |
| 66 | EIF2AK3 | 0.95276919 |
| 67 | SIK3 | 0.94200112 |
| 68 | PTK2B | 0.93263241 |
| 69 | SMG1 | 0.92176788 |
| 70 | MARK2 | 0.89042845 |
| 71 | MAP3K8 | 0.88773436 |
| 72 | TTN | 0.87558715 |
| 73 | ATR | 0.87021720 |
| 74 | MYLK | 0.86097836 |
| 75 | STK24 | 0.85431738 |
| 76 | CDK4 | 0.84299615 |
| 77 | LYN | 0.84134758 |
| 78 | MAPK11 | 0.81985037 |
| 79 | CDK19 | 0.80884327 |
| 80 | TRPM7 | 0.79766123 |
| 81 | JAK1 | 0.79434302 |
| 82 | MAPK12 | 0.78621212 |
| 83 | HIPK2 | 0.77196621 |
| 84 | PDK1 | 0.76480531 |
| 85 | AURKB | 0.76424439 |
| 86 | LCK | 0.75841609 |
| 87 | JAK2 | 0.74887006 |
| 88 | PRKD2 | 0.74502751 |
| 89 | PTK6 | 0.72891453 |
| 90 | MATK | 0.71691640 |
| 91 | SIK2 | 0.70612270 |
| 92 | ZAK | 0.70552428 |
| 93 | MAPKAPK5 | 0.70507144 |
| 94 | BRSK1 | 0.70415544 |
| 95 | CHUK | 0.67387542 |
| 96 | NEK1 | 0.66568138 |
| 97 | CDK7 | 0.65937904 |
| 98 | CCNB1 | 0.65265355 |
| 99 | RPS6KA5 | 0.65053487 |
| 100 | ILK | 0.64992190 |
| 101 | MAP3K7 | 0.63732839 |
| 102 | TAOK3 | 0.62595638 |
| 103 | RAF1 | 0.62193083 |
| 104 | CLK1 | 0.61211857 |
| 105 | PDPK1 | 0.61095352 |
| 106 | PRKCQ | 0.60652657 |
| 107 | BMPR2 | 0.60045309 |
| 108 | BMX | 0.59895410 |
| 109 | EIF2AK2 | 0.59265145 |
| 110 | GRK5 | 0.57700554 |
| 111 | FGFR4 | 0.57169035 |
| 112 | MAP2K6 | 0.55858012 |
| 113 | MAPKAPK2 | 0.55590753 |
| 114 | MAP3K6 | 0.54800807 |
| 115 | CDK8 | 0.54016479 |
| 116 | ABL2 | 0.53045230 |
| 117 | FYN | 0.52149301 |
| 118 | DYRK1B | 0.52035813 |
| 119 | MKNK1 | 0.50353838 |
| 120 | MAP3K5 | 0.49660639 |
| 121 | GRK6 | 0.48213590 |
| 122 | TAOK2 | 0.47485009 |
| 123 | HCK | 0.46494930 |
| 124 | CDK6 | 0.46364979 |
| 125 | STK11 | 0.44330558 |
| 126 | IRAK1 | 0.43947608 |
| 127 | YES1 | 0.43437075 |
| 128 | RPS6KA6 | 0.42760160 |
| 129 | PASK | 0.42643443 |
| 130 | ICK | 0.41805160 |
| 131 | NLK | 0.41070767 |
| 132 | SIK1 | 0.40766952 |
| 133 | PLK1 | 0.39455347 |
| 134 | MAPK4 | 0.39247680 |
| 135 | ITK | 0.38633573 |
| 136 | GRK7 | 0.36471062 |
| 137 | MAP2K4 | 0.36271602 |
| 138 | PAK4 | 0.36074904 |
| 139 | STK3 | 0.35845227 |
| 140 | MAPK7 | 0.34667605 |
| 141 | SGK3 | 0.34502563 |
| 142 | PIK3CG | 0.33925796 |
| 143 | MAP3K2 | 0.33549582 |
| 144 | RET | 0.32337671 |
| 145 | RPS6KL1 | 0.32242147 |
| 146 | RPS6KC1 | 0.32242147 |
| 147 | CDC42BPA | 0.30397971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.13236554 |
| 2 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.57656831 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.11638395 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.45601262 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.37240152 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17759322 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.08066685 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.03070370 |
| 9 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.95229100 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.80513685 |
| 11 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75461040 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.73326910 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.71495795 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71068014 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 1.70552458 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.69389514 |
| 17 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.66745333 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66489422 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65415147 |
| 20 | Proteasome_Homo sapiens_hsa03050 | 1.63516103 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61848005 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59207244 |
| 23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.54762645 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54571701 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54557242 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.52806098 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50742460 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50324719 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49959815 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47560851 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43653733 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.31759521 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.30633179 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.30397681 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25273562 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.23157435 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.22456854 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18076053 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.17432101 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.15934124 |
| 41 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.15286707 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.14092144 |
| 43 | * Malaria_Homo sapiens_hsa05144 | 1.13678493 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09173588 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08709680 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.07112258 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06916028 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06667375 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05377412 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.03912480 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.03674542 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00389341 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99571032 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.99145384 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98728375 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.96811581 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95262366 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95103509 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94415243 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93320518 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92478989 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92294806 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90655111 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.90539174 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89312279 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88398082 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.88314525 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.87114701 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86825608 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84404048 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84396549 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83587997 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80742316 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80183667 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78712551 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78048519 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76995121 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.75867927 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74477976 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73372100 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72490077 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72181349 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72173551 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71988513 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.70926724 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.70894625 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.67331891 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65908976 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63811582 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63535265 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63122470 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62104960 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61567111 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59744574 |
| 95 | Asthma_Homo sapiens_hsa05310 | 0.59122348 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58774585 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58543101 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58500610 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57513202 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55621888 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55175418 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54934775 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54490270 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54320472 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54040888 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53680292 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53533375 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.53276739 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52490148 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52153080 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50861797 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50529835 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49497562 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.49234656 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48843253 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48736693 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47210079 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47096529 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.45735603 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45207427 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.44917570 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44324668 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43296322 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43254421 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.42967439 |
| 126 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42595136 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42576191 |
| 128 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42139537 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41600877 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.41464026 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40932016 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40811687 |
| 133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39994022 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.39487160 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39454224 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39229926 |
| 137 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38126153 |
| 138 | Protein export_Homo sapiens_hsa03060 | 0.37677028 |
| 139 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36482669 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36480575 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36364807 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.34567410 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33861952 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32806665 |
| 145 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31941657 |
| 146 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31800503 |

